✦ LIBER ✦

Biologic and immunologic effects of preoperative trastuzumab for ductal carcinoma in situ of the breast

✍ Scribed by Henry M. Kuerer; Aman U. Buzdar; Elizabeth A. Mittendorf; Francisco J. Esteva; Anthony Lucci; Luis M. Vence; Laszlo Radvanyi; Funda Meric-Bernstam; Kelly K. Hunt; William Fraser Symmans

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 308 KB
Volume: 117
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.25399

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ductal carcinoma in situ of the breast

✍ Harris, Jules E. ;Bruetman, Daniel ;Bloom, Ken ;Bines, Steven 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 463 KB

Ductal carcinoma in situ of the male bre

Ductal carcinoma in situ of the male breast

✍ Mauricio G. Camus; Megha G. Joshi; Gasan Mackarem; Arthur K. C. Lee; Ricardo L. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 480 KB 👁 2 views

Background. Ductal carcinoma in situ (DCIS) of the male breast is an uncommon disease, accounting for approximately 7% of all male breast carcinomas. Compared with invasive carcinomas of the breast, the prognosis associated with DCIS in men is excellent; however, clinical features, pathology, and tr

Heterogeneity of ductal carcinoma in sit

Heterogeneity of ductal carcinoma in situ of the breast

✍ Michael D. Lagios 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 395 KB 👁 1 views

Ductal carcinoma in situ (DCIS) now accounts for 20-30% of all newly diagnosed breast cancers in centers which use mammographic surveillance as a standard part of the examination. The majority of these DCIS lesions, at least in the United States, are of very limited size, with mean estimated extents

A prognostic index for ductal carcinoma

A prognostic index for ductal carcinoma in situ of the breast

✍ Melvin J. Silverstein; Michael D. Lagios; Pamela H. Craig; James R. Waisman; Ber 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 663 KB

## BACKGROUND. There is controversy and confusion regarding therapy for patients with ductal carcinoma in situ (DCIS) of the breast. The Van Nuys Prognostic Index (VNPI) was developed to aid in the complex treatment selection process.

Thoughts about ductal carcinoma in situ

Thoughts about ductal carcinoma in situ of the breast

✍ Lawrence, Walter 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 31 KB 👁 2 views

Ductal carcinoma in situ (DCIS) was a relatively uncommon disease process when we relied on palpation to detect breast lesions. With the advent of more widespread mammography screenings, the surgeon is faced with a welcome opportunity to prevent cancer by dealing with a precursor lesion. Discovering

Extensive apoptosis in ductal carcinoma

Extensive apoptosis in ductal carcinoma in situ of the breast

✍ Stephan Bodis; Kalliopi P. Siziopikou; Stuart J. Schnitt; Jay R. Harris; David E 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 537 KB

## Background: More than 50% of breast ductal carcinomas in situ (dcis) contain significant histologic necrosis, an important prognostic factor for determining recurrence and progression to invasive breast cancer. we have examined whether the mechanism of this spontaneous cell death might be apopto